Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Hirsutism causes significant psychological distress in women.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The document concludes that a high-protein, low-carb diet can lead to significant weight loss but requires caution and further research.

Iodides can cause skin issues like acne and other health problems.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Current research explores hair growth drugs, while future research aims for personalized treatments.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Using SNP array testing helped quickly find the gene causing Woodhouse-Sakati syndrome in two related individuals.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Acne is a chronic skin condition not caused by poor hygiene or diet, and it requires long-term treatment and patient education.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Hair loss affects women's self-esteem; treatments like minoxidil can help.